1. PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway
   Yifeng Ding et al, 2024, Journal of Molecular Histology CrossRef
2. High thioredoxin reductase 1 expression in meningiomas undergoing malignant progression
   Hasan Esen et al, 2015, Brain Tumor Pathology CrossRef
3. Pancreatic Cancer Resistance to Gemcitabine
   P.S. Sushma et al, 2019, Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy CrossRef
4. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades
   Hasan Esen et al, 2015, Journal of Neuro-Oncology CrossRef
5. Podocalyxin in Normal Tissue and Epithelial Cancer
   Ngoc Le Tran et al, 2021, Cancers CrossRef
6. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma
   Ngoc Le Tran et al, 2024, Scientific Reports CrossRef
7. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas
   Hans-Juergen Schulten et al, 2019, PLOS ONE CrossRef
8. Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis
   Wen-Jie Chen et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef